Clinical Trial Update: Study Comparing The Effect On Disease Activity When Reducing Or Discontinuing Etanercept In Subjects With RA [Phase 4]

View source ↗

Summary

Phase 4 study evaluating how reducing or discontinuing etanercept affects disease activity in rheumatoid arthritis. The trial is completed with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Etanercept (etanercept)

Snippet

Sponsor: Pfizer | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2013-08-13